Welcome!

News Feed Item

Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2014

LONDON, Aug. 11, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2280941/Spastic-Cerebral-Palsy-Global-Clinical-Trials-Review-H2-2014.html

Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2014" provides data on the Spastic Cerebral Palsy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Spastic Cerebral Palsy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Spastic Cerebral Palsy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Spastic Cerebral Palsy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Unaccomplished Trials of Spastic Cerebral Palsy 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Spastic Cerebral Palsy Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Medy-Tox Inc. 29
Clinical Trial Overview of Medy-Tox Inc. 29
GlaxoSmithKline plc 30
Clinical Trial Overview of GlaxoSmithKline plc 30
Daiichi Sankyo Company, Limited 31
Clinical Trial Overview of Daiichi Sankyo Company, Limited 31
Clinical Trial Overview of Top Institutes / Government 32
All India Institute of Medical Sciences 32
Clinical Trial Overview of All India Institute of Medical Sciences 32
Gujarat Ayurved University 33
Clinical Trial Overview of Gujarat Ayurved University 33
Azienda Ospedaliera Istituti Clinici Di Perfezionamento 34
Clinical Trial Overview of Azienda Ospedaliera Istituti Clinici Di Perfezionamento 34
Duke University Medical Center 35
Clinical Trial Overview of Duke University Medical Center 35
Wright State University 36
Clinical Trial Overview of Wright State University 36
ALYN Pediatric and Adolescent Rehabilitation Center 37
Clinical Trial Overview of ALYN Pediatric and Adolescent Rehabilitation Center 37
Erasmus MC 38
Clinical Trial Overview of Erasmus MC 38
Chang Gung Memorial Foundation 39
Clinical Trial Overview of Chang Gung Memorial Foundation 39
National Center for Complementary and Alternative Medicine 40
Clinical Trial Overview of National Center for Complementary and Alternative Medicine 40
Stanford University 41
Clinical Trial Overview of Stanford University 41
Five Key Clinical Profiles 42
Appendix 57
Abbreviations 57
Definitions 57
Research Methodology 58
Secondary Research 58
About GlobalData 59
Contact Us 59
Disclaimer 59
Source 59

List of Tables

Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Region, 2014* 7
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Spastic Cerebral Palsy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Spastic Cerebral Palsy Therapeutics Clinical Trials, Europe, Top Countries, 2014* 11
Spastic Cerebral Palsy Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Spastic Cerebral Palsy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Spastic Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Spastic Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Spastic Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Spastic Cerebral Palsy Therapeutics, Global, Terminated Clinical Trials, 2014* 23
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Spastic Cerebral Palsy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 25
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Medy-Tox Inc., 2014* 29
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 30
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014* 31
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2014* 32
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Gujarat Ayurved University, 2014* 33
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera Istituti Clinici Di Perfezionamento, 2014* 34
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University Medical Center, 2014* 35
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Wright State University, 2014* 36
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by ALYN Pediatric and Adolescent Rehabilitation Center, 2014* 37
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014* 38
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Chang Gung Memorial Foundation, 2014* 39
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Complementary and Alternative Medicine, 2014* 40
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014* 41

List of Figures

Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Spastic Cerebral Palsy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Spastic Cerebral Palsy Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 11
Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Spastic Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Spastic Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Spastic Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Spastic Cerebral Palsy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 25
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28
GlobalData Methodology 58


Read the full report:
Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2280941/Spastic-Cerebral-Palsy-Global-Clinical-Trials-Review-H2-2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

 

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Today most companies are adopting or evaluating container technology - Docker in particular - to speed up application deployment, drive down cost, ease management and make application delivery more flexible overall. As with most new architectures, this dream takes significant work to become a reality. Even when you do get your application componentized enough and packaged properly, there are still challenges for DevOps teams to making the shift to continuous delivery and achieving that reducti...
21st International Cloud Expo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy. Me...
Real IoT production deployments running at scale are collecting sensor data from hundreds / thousands / millions of devices. The goal is to take business-critical actions on the real-time data and find insights from stored datasets. In his session at @ThingsExpo, John Walicki, Watson IoT Developer Advocate at IBM Cloud, will provide a fast-paced developer journey that follows the IoT sensor data from generation, to edge gateway, to edge analytics, to encryption, to the IBM Bluemix cloud, to Wa...
With the rise of DevOps, containers are at the brink of becoming a pervasive technology in Enterprise IT to accelerate application delivery for the business. When it comes to adopting containers in the enterprise, security is the highest adoption barrier. Is your organization ready to address the security risks with containers for your DevOps environment? In his session at @DevOpsSummit at 21st Cloud Expo, Chris Van Tuin, Chief Technologist, NA West at Red Hat, will discuss: The top security r...
SYS-CON Events announced today that Fusic will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Fusic Co. provides mocks as virtual IoT devices. You can customize mocks, and get any amount of data at any time in your test. For more information, visit https://fusic.co.jp/english/.
The “Digital Era” is forcing us to engage with new methods to build, operate and maintain applications. This transformation also implies an evolution to more and more intelligent applications to better engage with the customers, while creating significant market differentiators. In both cases, the cloud has become a key enabler to embrace this digital revolution. So, moving to the cloud is no longer the question; the new questions are HOW and WHEN. To make this equation even more complex, most ...
"NetApp's vision is how we help organizations manage data - delivering the right data in the right place, in the right time, to the people who need it, and doing it agnostic to what the platform is," explained Josh Atwell, Developer Advocate for NetApp, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
IBM helps FinTechs and financial services companies build and monetize cognitive-enabled financial services apps quickly and at scale. Hosted on IBM Bluemix, IBM’s platform builds in customer insights, regulatory compliance analytics and security to help reduce development time and testing. In his session at 21st Cloud Expo, Lennart Frantzell, a Developer Advocate with IBM, will discuss how these tools simplify the time-consuming tasks of selection, mapping and data integration, allowing devel...
Today traditional IT approaches leverage well-architected compute/networking domains to control what applications can access what data, and how. DevOps includes rapid application development/deployment leveraging concepts like containerization, third-party sourced applications and databases. Such applications need access to production data for its test and iteration cycles. Data Security? That sounds like a roadblock to DevOps vs. protecting the crown jewels to those in IT.
New competitors, disruptive technologies, and growing expectations are pushing every business to both adopt and deliver new digital services. This ‘Digital Transformation’ demands rapid delivery and continuous iteration of new competitive services via multiple channels, which in turn demands new service delivery techniques – including DevOps. In this power panel at @DevOpsSummit 20th Cloud Expo, moderated by DevOps Conference Co-Chair Andi Mann, panelists examined how DevOps helps to meet the de...
Cloud Expo, Inc. has announced today that Andi Mann and Aruna Ravichandran have been named Co-Chairs of @DevOpsSummit at Cloud Expo Silicon Valley which will take place Oct. 31-Nov. 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. "DevOps is at the intersection of technology and business-optimizing tools, organizations and processes to bring measurable improvements in productivity and profitability," said Aruna Ravichandran, vice president, DevOps product and solutions marketing...
SYS-CON Events announced today that B2Cloud will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. B2Cloud specializes in IoT devices for preventive and predictive maintenance in any kind of equipment retrieving data like Energy consumption, working time, temperature, humidity, pressure, etc.
Many organizations adopt DevOps to reduce cycle times and deliver software faster; some take on DevOps to drive higher quality and better end-user experience; others look to DevOps for a clearer line-of-sight to customers to drive better business impacts. In truth, these three foundations go together. In this power panel at @DevOpsSummit 21st Cloud Expo, moderated by DevOps Conference Co-Chair Andi Mann, industry experts will discuss how leading organizations build application success from all...
SYS-CON Events announced today that NetApp has been named “Bronze Sponsor” of SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. NetApp is the data authority for hybrid cloud. NetApp provides a full range of hybrid cloud data services that simplify management of applications and data across cloud and on-premises environments to accelerate digital transformation. Together with their partners, NetApp em...
Elon Musk is among the notable industry figures who worries about the power of AI to destroy rather than help society. Mark Zuckerberg, on the other hand, embraces all that is going on. AI is most powerful when deployed across the vast networks being built for Internets of Things in the manufacturing, transportation and logistics, retail, healthcare, government and other sectors. Is AI transforming IoT for the good or the bad? Do we need to worry about its potential destructive power? Or will we...